References
  1. Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am . 1998;45(3):511–529.
  2. Kalra VK, Lee HC, Sie L, Ratnasiri AW, Underwood MA, Lakshminrusimha S. Change in neonatal resuscitation guidelines and trends in incidence of meconium aspiration syndrome in California. J Perinatol . 2020;40(1):46‐55.
  3. Thornton PD, Campbell RT, Mogos MF et al. Meconium aspiration syndrome: Incidence and outcomes using discharge data. Early Hum. Dev . 2019;136: 21-26.
  4. Paudel P, Sunny AK, Poudel PG et al. Meconium aspiration syndrome: incidence, associated risk factors and outcome-evidence from a multicentric study in low-resource settings in Nepal. J Paediatr Child Health , 2020;56: 630-635.
  5. Anwar Z, Butt TK, Kazi MY. Mortality in meconium aspiration syndrome in hospitalized babies. J Coll Physicians Surg Pak . 2011;21(11):695-699.
  6. Qian L, Liu C, Zhuang W, et al. Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China.Pediatrics . 2008;121(5):e1115-e1124.
  7. Beligere N, Rao R. Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and literature review. J Perinatol . 2008;28 Suppl 3:S93-S101.
  8. Louis D, Sundaram V, Mukhopadhyay K, Dutta S, Kumar P. Predictors of mortality in neonates with meconium aspiration syndrome. Indian Pediatr . 2014;51(08):637–640
  9. Narayanan A, Batra P, Faridi MMA, Harit D. PaO2/FiO2 Ratio as Predictor of Mortality in Neonates with Meconium Aspiration Syndrome.Am J Perinatol . 2019;36(6):609‐614.
  10. Lin HC, Su BH, Lin TW, Peng CT, Tsai CH. Risk factors of mortality in meconium aspiration syndrome. Acta Pediatr TW 2004; 45: 30–34
  11. Kirkpatrick EC. Echocardiography in pediatric pulmonary hypertension.Paediatr Respir Rev . 2013;14(3):157‐164.
  12. Finlay ER, Subhedar NV. Pulmonary haemorrhage in preterm infants.Eur J Pediatr . 2000;159(11):870‐871.
  13. Steinhorn RH. Advances in Neonatal Pulmonary Hypertension.Neonatology . 2016;109(4):334‐344
  14. Vidyasagar D, Lukkarinen H, Kaapa P, Zagariya A. Inflammatory response and apoptosis in newborn lungs after meconium aspiration.Biotechnol Prog . 2005;21(1):192‐197.
  15. Fuloria M, Aschner JL, Persistent pulmonary hypertension of the newborn. Semin Fetal Neonatal Med. 2017, 22: 220-226.
  16. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics . 2000;105(1 Pt 1):14‐20.
  17. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med . 2000;342(7):469‐474.
  18. Hageman JR, Adams MA, Gardner TH. Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management. Am J Dis Child . 1984;138(6):592–595
  19. Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates.Cochrane Database Syst Rev . 2020;2(2):CD005254.
  20. Yen TA, Wang CC, Hsieh WS, Chou HC, Chen CY, Tsao PN. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants. Pediatr Neonatol . 2013;54(5):330‐334.
  21. Dufourq N, Thomson M, Adhikari M, Moodley J. Massive pulmonary haemorrhage as a cause of death in the neonate–a retrospective review. S Afr Med J . 2004;94(4):299‐302.
  22. Ferreira CH, Carmona F, Martinez FE. Prevalence, risk factors and outcomes associated with pulmonary hemorrhage in newborns. J Pediatr (Rio J) . 2014;90(3):316-322
  23. Long AM, Bunch KJ, Knight M, Kurinczuk JJ, Losty PD; BAPS-CASS. One-year outcomes of infants born with congenital diaphragmatic hernia: a national population cohort study. Arch Dis Child Fetal Neonatal Ed . 2019;104(6):643‐647.
  24. Condò V, Cipriani S, Colnaghi M, et al. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants?.J Matern Fetal Neonatal Med. 2017;30(11):1267-1272.
  25. Zhang L, Yang Y, Liu R, et al. A multiplex method for detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations. Int J Lab Hematol. 2015;37(6):739-745.